| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.722 | 0.021 | 0.722 | Caspase 9 stimulant | 0.678 0.026 CID_1983 | ||
| 0.578 | 0.014 | 0.61 | 5 Hydroxytryptamine release inhibitor | 0.61 0.01 CID_1983 | CID_1983 | |
| 0.52 | 0.022 | 0.52 | Aryl hydrocarbon receptor agonist | 0.445 0.03 CID_1983 | ||
| 0.505 | 0.027 | 0.575 | Histamine release inhibitor | 0.575 0.013 CID_1983 | CID_1983 | |
| 0.48 | 0.043 | 0.48 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.476 0.045 CID_1983 | ||
| 0.424 | 0.008 | 0.677 | Alpha-N-acetylglucosaminidase inhibitor | 0.677 0.003 CID_1983 | CID_1983 | |
| 0.427 | 0.017 | 0.646 | Peroxidase inhibitor | 0.646 0.004 CID_1983 | CID_1983 | |
| 0.433 | 0.031 | 0.433 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.427 0.032 CID_1983 | ||
| 0.408 | 0.018 | 0.462 | Interleukin agonist | 0.462 0.012 CID_1983 | CID_1983 | |
| 0.472 | 0.094 | 0.472 | DNA polymerase beta inhibitor | 0.421 0.111 CID_1983 | ||
| 0.418 | 0.052 | 0.418 | Calpain 2 inhibitor | 0.401 0.061 CID_1983 | ||
| 0.414 | 0.055 | 0.569 | GABA C receptor rho-3 antagonist | 0.569 0.011 CID_1983 | CID_1983 | |
| 0.404 | 0.054 | 0.404 | Vasodilator, peripheral | 0.392 0.058 CID_1983 | ||
| 0.381 | 0.033 | 0.469 | Interleukin 2 agonist | 0.469 0.012 CID_1983 | CID_1983 | |
| 0.36 | 0.029 | 0.372 | Transcription factor STAT3 inhibitor | 0.372 0.026 CID_1983 | CID_1983 | |
| 0.363 | 0.034 | 0.405 | Superoxide dismutase inhibitor | 0.405 0.026 CID_1983 | CID_1983 | |
| 0.406 | 0.077 | 0.498 | Calcium channel L-type activator | 0.498 0.029 CID_1983 | CID_1983 | |
| 0.43 | 0.104 | 0.43 | DNA directed DNA polymerase inhibitor | 0.41 0.111 CID_1983 | ||
| 0.35 | 0.034 | 0.387 | Transcription factor STAT inhibitor | 0.387 0.022 CID_1983 | CID_1983 | |
| 0.33 | 0.015 | 0.33 | 5 Hydroxytryptamine 1E antagonist | 0.317 0.02 CID_1983 | ||
| 0.359 | 0.044 | 0.359 | Calcium channel activator | 0.307 0.085 CID_1983 | ||
| 0.318 | 0.005 | 0.318 | Cyclooxygenase 3 inhibitor | 0.314 0.005 CID_1983 | ||
| 0.326 | 0.017 | 0.361 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.361 0.011 CID_1983 | CID_1983 | |
| 0.416 | 0.108 | 0.482 | Alpha-glucosidase inhibitor | 0.482 0.086 CID_1983 | CID_1983 | |
| 0.314 | 0.009 | 0.314 | 3C-like protease (Human coronavirus) inhibitor | 0.269 0.02 CID_1983 | ||
| 0.408 | 0.106 | 0.408 | Transcription factor inhibitor | 0.351 0.13 CID_1983 | ||
| 0.323 | 0.028 | 0.381 | Anesthetic general | 0.381 0.019 CID_1983 | CID_1983 | |
| 0.35 | 0.055 | 0.559 | Aldehyde oxidase inhibitor | 0.559 0.025 CID_1983 | CID_1983 | |
| 0.395 | 0.101 | 0.395 | Beta lactamase inhibitor | 0.206 0.181 CID_1983 | ||
| 0.354 | 0.072 | 0.354 | Thyroid hormone antagonist | 0.306 0.09 CID_1983 | ||
| 0.35 | 0.068 | 0.35 | Thyroid hormone beta antagonist | 0.29 0.093 CID_1983 | ||
| 0.343 | 0.074 | 0.343 | Angiogenesis inhibitor | 0.256 0.119 CID_1983 | ||
| 0.278 | 0.018 | 0.3 | Nitric-oxide synthase stimulant | 0.3 0.011 CID_1983 | CID_1983 | |
| 0.267 | 0.01 | 0.317 | Carbonic anhydrase XV inhibitor | 0.317 0.007 CID_1983 | CID_1983 | |
| 0.298 | 0.046 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.325 0.034 CID_1983 | CID_1983 | |
| 0.29 | 0.038 | 0.41 | Tyrosine 3 hydroxylase inhibitor | 0.41 0.007 CID_1983 | CID_1983 | |
| 0.278 | 0.032 | 0.297 | Neuropeptide Y2 antagonist | 0.297 0.02 CID_1983 | CID_1983 | |
| 0.299 | 0.059 | 0.355 | Insulysin inhibitor | 0.355 0.032 CID_1983 | CID_1983 | |
| 0.253 | 0.015 | 0.253 | 5 Hydroxytryptamine 3E antagonist | 0.241 0.02 CID_1983 | ||
| 0.253 | 0.021 | 0.29 | Succinate dehydrogenase inhibitor | 0.29 0.012 CID_1983 | CID_1983 | |
| 0.28 | 0.049 | 0.282 | Gastrin inhibitor | 0.282 0.047 CID_1983 | CID_1983 | |
| 0.247 | 0.018 | 0.322 | Hexokinase inhibitor | 0.322 0.009 CID_1983 | CID_1983 | |
| 0.268 | 0.039 | 0.271 | DNA methyltransferase I inhibitor | 0.271 0.038 CID_1983 | CID_1983 | |
| 0.24 | 0.016 | 0.294 | Death-associated protein kinase 2 inhibitor | 0.294 0.007 CID_1983 | CID_1983 | |
| 0.302 | 0.078 | 0.376 | 12-Lipoxygenase inhibitor | 0.376 0.046 CID_1983 | CID_1983 | |
| 0.231 | 0.012 | 0.264 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.264 0.009 CID_1983 | CID_1983 | |
| 0.27 | 0.055 | 0.401 | Interleukin antagonist | 0.401 0.031 CID_1983 | CID_1983 | |
| 0.246 | 0.03 | 0.246 | Cytidine deaminase inhibitor | 0.204 0.046 CID_1983 | ||
| 0.289 | 0.073 | 0.327 | 5 Hydroxytryptamine release stimulant | 0.327 0.062 CID_1983 | CID_1983 | |
| 0.225 | 0.012 | 0.341 | Carbonic anhydrase III inhibitor | 0.341 0.005 CID_1983 | CID_1983 | |
| 0.223 | 0.012 | 0.223 | Falcipain 3 inhibitor | 0.21 0.015 CID_1983 | ||
| 0.224 | 0.017 | 0.341 | Ferrochelatase inhibitor | 0.341 0.005 CID_1983 | CID_1983 | |
| 0.231 | 0.025 | 0.253 | NADPH oxidase inhibitor | 0.253 0.02 CID_1983 | CID_1983 | |
| 0.322 | 0.117 | 0.403 | 15-Lipoxygenase inhibitor | 0.403 0.073 CID_1983 | CID_1983 | |
| 0.253 | 0.05 | 0.253 | ErbB-1 antagonist | 0.236 0.059 CID_1983 | ||
| 0.219 | 0.024 | 0.234 | ATPase inhibitor | 0.234 0.018 CID_1983 | CID_1983 | |
| 0.21 | 0.017 | 0.231 | CF transmembrane conductance regulator agonist | 0.231 0.01 CID_1983 | CID_1983 | |
| 0.253 | 0.062 | 0.253 | Calpain inhibitor | 0.252 0.063 CID_1983 | ||
| 0.204 | 0.013 | 0.21 | Mucolytic | 0.21 0.011 CID_1983 | CID_1983 | |
| 0.201 | 0.01 | 0.248 | Papain-like protease (SARS coronavirus) inhibitor | 0.248 0.005 CID_1983 | CID_1983 | |
| 0.336 | 0.146 | 0.336 | MAP kinase 1 inhibitor | 0.244 0.241 CID_1983 | ||
| 0.235 | 0.045 | 0.235 | I kappa B kinase epsilon inhibitor | 0.201 0.07 CID_1983 | ||
| 0.228 | 0.038 | 0.228 | Tumour necrosis factor antagonist | 0.131 0.125 CID_1983 | ||
| 0.221 | 0.031 | 0.221 | Tubulin antagonist | |||
| 0.288 | 0.099 | 0.344 | Cholesterol antagonist | 0.344 0.067 CID_1983 | CID_1983 | |
| 0.242 | 0.053 | 0.242 | DNA methylase inhibitor | 0.242 0.053 CID_1983 | ||
| 0.243 | 0.056 | 0.316 | Peptidyltransferase inhibitor | 0.316 0.019 CID_1983 | CID_1983 | |
| 0.232 | 0.047 | 0.232 | Focal adhesion kinase 2 inhibitor | 0.156 0.122 CID_1983 | ||
| 0.188 | 0.005 | 0.188 | Glutamate (mGluR7) agonist | 0.128 0.023 CID_1983 | ||
| 0.275 | 0.093 | 0.275 | Caspase 3 stimulant | 0.257 0.106 CID_1983 | ||
| 0.202 | 0.023 | 0.236 | Toll-Like receptor 2 antagonist | 0.236 0.012 CID_1983 | CID_1983 | |
| 0.207 | 0.03 | 0.227 | M17 leucyl aminopeptidase inhibitor | 0.227 0.025 CID_1983 | CID_1983 | |
| 0.243 | 0.067 | 0.243 | Cyclic AMP phosphodiesterase inhibitor | 0.243 0.067 CID_1983 | ||
| 0.191 | 0.016 | 0.208 | Sphingosine 1-phosphate receptor 5 antagonist | 0.208 0.009 CID_1983 | CID_1983 | |
| 0.281 | 0.106 | 0.352 | Transcription factor NF kappa B inhibitor | 0.352 0.076 CID_1983 | CID_1983 | |
| 0.279 | 0.106 | 0.279 | Vasodilator, coronary | 0.247 0.138 CID_1983 | ||
| 0.187 | 0.018 | 0.226 | Catalase inhibitor | 0.226 0.011 CID_1983 | CID_1983 | |
| 0.191 | 0.022 | 0.197 | Expectorant | 0.197 0.021 CID_1983 | CID_1983 | |
| 0.198 | 0.03 | 0.218 | GABA C receptor rho-2 antagonist | 0.218 0.02 CID_1983 | CID_1983 | |
| 0.172 | 0.005 | 0.232 | Neuraminidase (influenza) inhibitor | 0.232 0.004 CID_1983 | CID_1983 | |
| 0.279 | 0.115 | 0.279 | Thioredoxin glutathione reductase inhibitor | 0.258 0.129 CID_1983 | ||
| 0.196 | 0.035 | 0.206 | Cyclin-dependent kinase 3 inhibitor | 0.206 0.03 CID_1983 | CID_1983 | |
| 0.226 | 0.066 | 0.263 | MAP kinase kinase 2 inhibitor | 0.263 0.048 CID_1983 | CID_1983 | |
| 0.161 | 0.005 | 0.224 | Neuraminidase inhibitor | 0.224 0.004 CID_1983 | CID_1983 | |
| 0.174 | 0.018 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.189 0.011 CID_1983 | CID_1983 | |
| 0.215 | 0.063 | 0.292 | Neurotrophic factor enhancer | 0.292 0.02 CID_1983 | CID_1983 | |
| 0.17 | 0.019 | 0.17 | Sphingosine 1-phosphate receptor 4 antagonist | 0.168 0.02 CID_1983 | ||
| 0.191 | 0.04 | 0.223 | Neurotensin receptor agonist | 0.223 0.026 CID_1983 | CID_1983 | |
| 0.17 | 0.023 | 0.34 | UDP-glucose 4-epimerase inhibitor | 0.34 0.008 CID_1983 | CID_1983 | |
| 0.216 | 0.073 | 0.285 | Pyruvate kinase inhibitor | 0.285 0.051 CID_1983 | CID_1983 | |
| 0.174 | 0.032 | 0.287 | Interleukin 4 antagonist | 0.287 0.009 CID_1983 | CID_1983 | |
| 0.17 | 0.028 | 0.17 | Interleukin 1b antagonist | |||
| 0.163 | 0.024 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 CID_1983 | CID_1983 | |
| 0.157 | 0.022 | 0.173 | CDK3/cyclin E inhibitor | 0.173 0.014 CID_1983 | CID_1983 | |
| 0.161 | 0.026 | 0.161 | Death-associated protein kinase 1 inhibitor | 0.148 0.042 CID_1983 | ||
| 0.203 | 0.07 | 0.215 | Insulin sensitizer | 0.215 0.059 CID_1983 | CID_1983 | |
| 0.171 | 0.038 | 0.171 | Neuropeptide Y1 antagonist | 0.17 0.039 CID_1983 | ||
| 0.194 | 0.061 | 0.215 | Amyloid beta precursor protein antagonist | 0.215 0.048 CID_1983 | CID_1983 | |
| 0.172 | 0.04 | 0.172 | Anesthetic local | 0.155 0.046 CID_1983 | ||
| 0.21 | 0.078 | 0.21 | Antimitotic | |||
| 0.152 | 0.021 | 0.194 | Carbonic anhydrase XIII inhibitor | 0.194 0.015 CID_1983 | CID_1983 | |
| 0.145 | 0.016 | 0.181 | Carbonic anhydrase V inhibitor | 0.181 0.009 CID_1983 | CID_1983 | |
| 0.137 | 0.008 | 0.137 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.022 CID_1983 | ||
| 0.178 | 0.051 | 0.219 | Protein kinase stimulant | 0.219 0.035 CID_1983 | CID_1983 | |
| 0.138 | 0.012 | 0.678 | Alcohol oxidase inhibitor | 0.678 0.003 CID_1983 | CID_1983 | |
| 0.131 | 0.006 | 0.154 | NMDA receptor glycine site agonist | 0.154 0.004 CID_1983 | CID_1983 | |
| 0.135 | 0.014 | 0.164 | Carbonic anhydrase VA inhibitor | 0.164 0.008 CID_1983 | CID_1983 | |
| 0.196 | 0.075 | 0.196 | Non-steroidal antiinflammatory agent | 0.184 0.084 CID_1983 | ||
| 0.143 | 0.022 | 0.143 | Acetylcholine release stimulant | 0.106 0.075 CID_1983 | ||
| 0.145 | 0.027 | 0.145 | Sphingomyelinase inhibitor | 0.101 0.059 CID_1983 | ||
| 0.128 | 0.01 | 0.169 | D-Ala-D-Ala ligase inhibitor | 0.169 0.004 CID_1983 | CID_1983 | |
| 0.153 | 0.035 | 0.155 | Vanilloid 1 agonist | 0.155 0.033 CID_1983 | CID_1983 | |
| 0.187 | 0.069 | 0.205 | LIM domain kinase 1 inhibitor | 0.205 0.061 CID_1983 | CID_1983 | |
| 0.167 | 0.05 | 0.167 | Cytokine production inhibitor | 0.116 0.094 CID_1983 | ||
| 0.146 | 0.031 | 0.156 | Caspase 3 inhibitor | 0.156 0.024 CID_1983 | CID_1983 | |
| 0.166 | 0.05 | 0.179 | Alkaline phosphatase inhibitor | 0.179 0.043 CID_1983 | CID_1983 | |
| 0.206 | 0.091 | 0.252 | RNA-directed DNA polymerase inhibitor | 0.252 0.048 CID_1983 | CID_1983 | |
| 0.217 | 0.102 | 0.223 | DNA damaging | 0.223 0.098 CID_1983 | CID_1983 | |
| 0.189 | 0.074 | 0.202 | Growth factor agonist | 0.202 0.061 CID_1983 | CID_1983 | |
| 0.119 | 0.005 | 0.119 | Cyclin D1 inhibitor | 0.094 0.01 CID_1983 | ||
| 0.141 | 0.028 | 0.159 | Urease inhibitor | 0.159 0.019 CID_1983 | CID_1983 | |
| 0.153 | 0.044 | 0.153 | Cathepsin H inhibitor | 0.152 0.045 CID_1983 | ||
| 0.218 | 0.11 | 0.337 | Immunostimulant | 0.337 0.068 CID_1983 | CID_1983 | |
| 0.11 | 0.004 | 0.125 | Dihydropteroate synthase inhibitor | 0.125 0.004 CID_1983 | CID_1983 | |
| 0.172 | 0.068 | 0.241 | Heat shock protein 90 alpha antagonist | 0.241 0.03 CID_1983 | CID_1983 | |
| 0.207 | 0.103 | 0.207 | Tumour necrosis factor alpha release inhibitor | |||
| 0.142 | 0.04 | 0.142 | DNA repair enzyme inhibitor | 0.14 0.042 CID_1983 | ||
| 0.112 | 0.011 | 0.112 | Potassium channel (ATP-sensitive) blocker | 0.093 0.019 CID_1983 | ||
| 0.165 | 0.064 | 0.19 | Melanin inhibitor | 0.19 0.045 CID_1983 | CID_1983 | |
| 0.16 | 0.06 | 0.16 | Vascular endothelial growth factor 3 antagonist | |||
| 0.168 | 0.068 | 0.191 | Arachidonic acid antagonist | 0.191 0.041 CID_1983 | CID_1983 | |
| 0.174 | 0.075 | 0.174 | MAP kinase kinase 5 inhibitor | |||
| 0.147 | 0.049 | 0.147 | Antibacterial (Helicobacter pylori) | 0.143 0.053 CID_1983 | ||
| 0.102 | 0.005 | 0.102 | Melatonin agonist | 0.03 0.028 CID_1983 | ||
| 0.15 | 0.053 | 0.161 | Pregnane X receptor agonist | 0.161 0.036 CID_1983 | CID_1983 | |
| 0.198 | 0.101 | 0.208 | Antiamyloidogenic | 0.208 0.094 CID_1983 | CID_1983 | |
| 0.169 | 0.074 | 0.257 | Phospholipase C inhibitor | 0.257 0.024 CID_1983 | CID_1983 | |
| 0.099 | 0.005 | 0.099 | Melatonin antagonist | 0.027 0.022 CID_1983 | ||
| 0.167 | 0.072 | 0.203 | Catenin beta inhibitor | 0.203 0.03 CID_1983 | CID_1983 | |
| 0.16 | 0.066 | 0.194 | Interferon gamma antagonist | 0.194 0.043 CID_1983 | CID_1983 | |
| 0.138 | 0.045 | 0.151 | MAO A inhibitor | 0.151 0.041 CID_1983 | CID_1983 | |
| 0.106 | 0.013 | 0.133 | Beta 3 adrenoreceptor antagonist | 0.133 0.008 CID_1983 | CID_1983 | |
| 0.131 | 0.038 | 0.131 | Platelet activating factor alpha antagonist | |||
| 0.126 | 0.035 | 0.126 | Breast cancer-resistant protein inhibitor | |||
| 0.104 | 0.014 | 0.129 | GABA B receptor agonist | 0.129 0.005 CID_1983 | CID_1983 | |
| 0.096 | 0.005 | 0.096 | Inosine monophosphate dehydrogenase inhibitor | 0.06 0.01 CID_1983 | ||
| 0.134 | 0.044 | 0.154 | TRPA1 agonist | 0.154 0.028 CID_1983 | CID_1983 | |
| 0.119 | 0.03 | 0.209 | Carbonic anhydrase VI inhibitor | 0.209 0.012 CID_1983 | CID_1983 | |
| 0.184 | 0.094 | 0.184 | Histone acetyltransferase inhibitor | 0.176 0.105 CID_1983 | ||
| 0.137 | 0.047 | 0.222 | Cystathionine beta-synthase inhibitor | 0.222 0.02 CID_1983 | CID_1983 | |
| 0.115 | 0.026 | 0.115 | Glutamate release inhibitor | 0.094 0.054 CID_1983 | ||
| 0.142 | 0.053 | 0.142 | Nav1.3 sodium channel blocker | 0.11 0.086 CID_1983 | ||
| 0.119 | 0.03 | 0.119 | Toll-Like receptor 3 antagonist | |||
| 0.105 | 0.017 | 0.172 | NMDA receptor agonist | 0.172 0.006 CID_1983 | CID_1983 | |
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | 0.081 0.026 CID_1983 | ||
| 0.178 | 0.09 | 0.252 | Amyloid beta aggregation inhibitor | 0.252 0.057 CID_1983 | CID_1983 | |
| 0.092 | 0.006 | 0.141 | Dihydroorotate oxidase inhibitor | 0.141 0.003 CID_1983 | CID_1983 | |
| 0.15 | 0.064 | 0.224 | Amylase inhibitor | 0.224 0.036 CID_1983 | CID_1983 | |
| 0.138 | 0.052 | 0.229 | Monophenol monooxygenase inhibitor | 0.229 0.027 CID_1983 | CID_1983 | |
| 0.146 | 0.062 | 0.146 | MAO inhibitor | 0.146 0.062 CID_1983 | ||
| 0.11 | 0.029 | 0.126 | Glutathione S-transferase inhibitor | 0.126 0.019 CID_1983 | CID_1983 | |
| 0.102 | 0.022 | 0.128 | Estrogen-related receptor beta agonist | 0.128 0.007 CID_1983 | CID_1983 | |
| 0.128 | 0.049 | 0.165 | 5 Hydroxytryptamine 3A agonist | 0.165 0.028 CID_1983 | CID_1983 | |
| 0.146 | 0.068 | 0.154 | Mannose-6-phosphate isomerase inhibitor | 0.154 0.061 CID_1983 | CID_1983 | |
| 0.12 | 0.043 | 0.12 | CDC-like kinase 3 inhibitor | 0.112 0.055 CID_1983 | ||
| 0.229 | 0.152 | 0.329 | Sodium/bile acid cotransporter inhibitor | 0.329 0.055 CID_1983 | CID_1983 | |
| 0.144 | 0.067 | 0.144 | Toll-Like receptor 9 antagonist | |||
| 0.081 | 0.005 | 0.081 | Melatonin 2 agonist | 0.035 0.02 CID_1983 | ||
| 0.126 | 0.05 | 0.138 | Photosensitizer | 0.138 0.039 CID_1983 | CID_1983 | |
| 0.081 | 0.005 | 0.081 | Melatonin 1 agonist | 0.031 0.027 CID_1983 | ||
| 0.102 | 0.026 | 0.102 | Adenosine A3 receptor antagonist | 0.099 0.027 CID_1983 | ||
| 0.083 | 0.007 | 0.083 | Ryanodine receptor antagonist | 0.065 0.025 CID_1983 | ||
| 0.126 | 0.05 | 0.165 | Transcription factor STAT6 inhibitor | 0.165 0.014 CID_1983 | CID_1983 | |
| 0.089 | 0.014 | 0.106 | Carbonic anhydrase XIV inhibitor | 0.106 0.009 CID_1983 | CID_1983 | |
| 0.117 | 0.042 | 0.169 | HIV-1 integrase (Overall Integration) inhibitor | 0.169 0.019 CID_1983 | CID_1983 | |
| 0.109 | 0.035 | 0.152 | NADH dehydrogenase inhibitor | 0.152 0.017 CID_1983 | CID_1983 | |
| 0.077 | 0.003 | 0.077 | Melatonin receptor 1A antagonist | |||
| 0.078 | 0.005 | 0.103 | Neuraminidase (Influenza A) inhibitor | 0.103 0.004 CID_1983 | CID_1983 | |
| 0.114 | 0.041 | 0.129 | Interleukin 1 beta converting enzyme inhibitor | 0.129 0.028 CID_1983 | CID_1983 | |
| 0.129 | 0.056 | 0.179 | Protein kinase (CK2) alpha inhibitor | 0.179 0.029 CID_1983 | CID_1983 | |
| 0.098 | 0.026 | 0.098 | Amidase inhibitor | 0.09 0.03 CID_1983 | ||
| 0.094 | 0.022 | 0.094 | Secretase beta inhibitor | 0.086 0.03 CID_1983 | ||
| 0.079 | 0.007 | 0.079 | Heparanase inhibitor | 0.076 0.008 CID_1983 | ||
| 0.102 | 0.031 | 0.128 | Glycine receptor antagonist | 0.128 0.014 CID_1983 | CID_1983 | |
| 0.119 | 0.049 | 0.151 | Mediator release inhibitor | 0.151 0.028 CID_1983 | CID_1983 | |
| 0.075 | 0.004 | 0.075 | Melatonin receptor 1A agonist | |||
| 0.129 | 0.06 | 0.155 | Alkylator | 0.155 0.044 CID_1983 | CID_1983 | |
| 0.116 | 0.047 | 0.131 | Toll-Like receptor 4 antagonist | 0.131 0.034 CID_1983 | CID_1983 | |
| 0.1 | 0.031 | 0.16 | Keratolytic | 0.16 0.013 CID_1983 | CID_1983 | |
| 0.089 | 0.021 | 0.157 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.157 0.006 CID_1983 | CID_1983 | |
| 0.204 | 0.136 | 0.256 | Lipoxygenase inhibitor | 0.256 0.096 CID_1983 | CID_1983 | |
| 0.074 | 0.006 | 0.074 | Diamine oxidase inhibitor | 0.051 0.014 CID_1983 | ||
| 0.144 | 0.076 | 0.173 | Hemostatic | 0.173 0.047 CID_1983 | CID_1983 | |
| 0.092 | 0.025 | 0.092 | Beta tubulin antagonist | 0.053 0.044 CID_1983 | ||
| 0.082 | 0.015 | 0.082 | Transcription factor RelA inhibitor | 0.074 0.024 CID_1983 | ||
| 0.123 | 0.057 | 0.123 | Microtubule formation inhibitor | 0.118 0.063 CID_1983 | ||
| 0.22 | 0.154 | 0.27 | Antithrombotic | 0.27 0.111 CID_1983 | CID_1983 | |
| 0.113 | 0.047 | 0.153 | GABA C receptor rho-1 antagonist | 0.153 0.02 CID_1983 | CID_1983 | |
| 0.071 | 0.004 | 0.071 | Melatonin 1 antagonist | |||
| 0.108 | 0.042 | 0.138 | Interleukin 12 antagonist | 0.138 0.017 CID_1983 | CID_1983 | |
| 0.078 | 0.013 | 0.122 | Carbonic anhydrase VII inhibitor | 0.122 0.008 CID_1983 | CID_1983 | |
| 0.145 | 0.08 | 0.202 | Heat shock protein 90 antagonist | 0.202 0.037 CID_1983 | CID_1983 | |
| 0.107 | 0.043 | 0.107 | Calcium antagonist | |||
| 0.139 | 0.076 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.031 CID_1983 | CID_1983 | |
| 0.107 | 0.044 | 0.107 | Potassium channel (Voltage-sensitive) activator | 0.097 0.057 CID_1983 | ||
| 0.104 | 0.042 | 0.104 | Phosphodiesterase IV inhibitor | |||
| 0.111 | 0.049 | 0.15 | Anabolic | 0.15 0.018 CID_1983 | CID_1983 | |
| 0.108 | 0.047 | 0.126 | MAP kinase kinase 1 inhibitor | 0.126 0.029 CID_1983 | CID_1983 | |
| 0.206 | 0.145 | 0.218 | Hypoxia-inducible factor 1 alpha inhibitor | 0.218 0.131 CID_1983 | CID_1983 | |
| 0.135 | 0.075 | 0.187 | Histone deacetylase SIRT1 inhibitor | 0.187 0.036 CID_1983 | CID_1983 | |
| 0.073 | 0.013 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.017 CID_1983 | ||
| 0.068 | 0.008 | 0.068 | Benzodiazepine antagonist | 0.044 0.042 CID_1983 | ||
| 0.103 | 0.044 | 0.164 | Androgen antagonist | 0.164 0.019 CID_1983 | CID_1983 | |
| 0.114 | 0.055 | 0.114 | Electron transport complex I inhibitor | |||
| 0.123 | 0.064 | 0.123 | Beta amyloid protein antagonist | |||
| 0.193 | 0.134 | 0.251 | DNA synthesis inhibitor | 0.251 0.066 CID_1983 | CID_1983 | |
| 0.13 | 0.072 | 0.13 | Nav1.2 sodium channel blocker | 0.111 0.095 CID_1983 | ||
| 0.078 | 0.02 | 0.125 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.125 0.005 CID_1983 | CID_1983 | |
| 0.097 | 0.039 | 0.141 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.141 0.021 CID_1983 | CID_1983 | |
| 0.137 | 0.08 | 0.137 | CDC-like kinase 1 inhibitor | |||
| 0.098 | 0.042 | 0.098 | Bromodomain-containing protein 2 inhibitor | 0.08 0.078 CID_1983 | ||
| 0.102 | 0.046 | 0.172 | Triose-phosphate isomerase inhibitor | 0.172 0.015 CID_1983 | CID_1983 | |
| 0.098 | 0.042 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.087 0.063 CID_1983 | ||
| 0.082 | 0.026 | 0.102 | Beta adrenoreceptor antagonist | 0.102 0.015 CID_1983 | CID_1983 | |
| 0.12 | 0.065 | 0.132 | Proteasome inhibitor | 0.132 0.057 CID_1983 | CID_1983 | |
| 0.077 | 0.024 | 0.138 | Carbonic anhydrase VB inhibitor | 0.138 0.01 CID_1983 | CID_1983 | |
| 0.138 | 0.085 | 0.177 | Adenylate cyclase stimulant | 0.177 0.028 CID_1983 | CID_1983 | |
| 0.066 | 0.013 | 0.073 | Dihydroorotase inhibitor | 0.073 0.01 CID_1983 | CID_1983 | |
| 0.059 | 0.007 | 0.059 | Cyclin E2 inhibitor | 0.05 0.009 CID_1983 | ||
| 0.09 | 0.037 | 0.127 | CC chemokine 5 receptor agonist | 0.127 0.006 CID_1983 | CID_1983 | |
| 0.129 | 0.077 | 0.129 | Interleukin 1 antagonist | |||
| 0.091 | 0.04 | 0.091 | Caspase 7 inhibitor | |||
| 0.074 | 0.023 | 0.085 | Beta 1 adrenoreceptor antagonist | 0.085 0.015 CID_1983 | CID_1983 | |
| 0.1 | 0.048 | 0.141 | Potassium channel activator | 0.141 0.023 CID_1983 | CID_1983 | |
| 0.204 | 0.153 | 0.217 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.217 0.139 CID_1983 | CID_1983 | |
| 0.065 | 0.015 | 0.065 | Potassium channel (Inward rectifier) activator | 0.064 0.016 CID_1983 | ||
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | |||
| 0.103 | 0.054 | 0.14 | Electrolyte absorption antagonist | 0.14 0.024 CID_1983 | CID_1983 | |
| 0.055 | 0.006 | 0.055 | Carnitine palmitoyltransferase inhibitor | 0.034 0.023 CID_1983 | ||
| 0.054 | 0.006 | 0.054 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.023 CID_1983 | ||
| 0.202 | 0.155 | 0.217 | Prostaglandin dehydrogenase inhibitor | 0.217 0.146 CID_1983 | CID_1983 | |
| 0.066 | 0.018 | 0.132 | Topoisomerase II beta inhibitor | 0.132 0.006 CID_1983 | CID_1983 | |
| 0.118 | 0.071 | 0.158 | Histone deacetylase class III inhibitor | 0.158 0.038 CID_1983 | CID_1983 | |
| 0.061 | 0.015 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_1983 | ||
| 0.085 | 0.039 | 0.22 | Histidine decarboxylase inhibitor | 0.22 0.011 CID_1983 | CID_1983 | |
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.08 | 0.034 | 0.08 | Acetylcholine M5 receptor agonist | |||
| 0.092 | 0.047 | 0.092 | Platelet growth factor antagonist | |||
| 0.063 | 0.018 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 CID_1983 | CID_1983 | |
| 0.071 | 0.027 | 0.091 | Histone deacetylase SIRT3 inhibitor | 0.091 0.013 CID_1983 | CID_1983 | |
| 0.085 | 0.041 | 0.134 | GABA aminotransferase inhibitor | 0.134 0.011 CID_1983 | CID_1983 | |
| 0.21 | 0.166 | 0.283 | Apoptosis antagonist | 0.283 0.098 CID_1983 | CID_1983 | |
| 0.138 | 0.094 | 0.138 | Sigma receptor agonist | |||
| 0.098 | 0.055 | 0.108 | Phosphodiesterase 6D inhibitor | 0.108 0.039 CID_1983 | CID_1983 | |
| 0.105 | 0.062 | 0.229 | GABA C receptor agonist | 0.229 0.016 CID_1983 | CID_1983 | |
| 0.253 | 0.211 | 0.292 | Apoptosis agonist | 0.292 0.178 CID_1983 | CID_1983 | |
| 0.07 | 0.028 | 0.07 | Kallikrein 7 inhibitor | |||
| 0.064 | 0.021 | 0.064 | Adenosine A2b receptor antagonist | 0.048 0.035 CID_1983 | ||
| 0.09 | 0.049 | 0.104 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.104 0.035 CID_1983 | CID_1983 | |
| 0.077 | 0.036 | 0.077 | Fibroblast growth factor 2 antagonist | |||
| 0.156 | 0.115 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.189 0.085 CID_1983 | CID_1983 | |
| 0.048 | 0.007 | 0.048 | Epoxide hydrolase 1 inhibitor | 0.037 0.014 CID_1983 | ||
| 0.097 | 0.056 | 0.111 | Bile acid receptor antagonist | 0.111 0.029 CID_1983 | CID_1983 | |
| 0.081 | 0.041 | 0.081 | Epoxide hydrolase inhibitor | 0.074 0.048 CID_1983 | ||
| 0.128 | 0.088 | 0.2 | Cell wall synthesis inhibitor | 0.2 0.03 CID_1983 | CID_1983 | |
| 0.066 | 0.027 | 0.066 | Alpha tubulin antagonist | 0.054 0.036 CID_1983 | ||
| 0.069 | 0.03 | 0.069 | Calcium channel P-type blocker | |||
| 0.074 | 0.036 | 0.074 | Exportin-1 inhibitor | |||
| 0.069 | 0.032 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 CID_1983 | CID_1983 | |
| 0.041 | 0.005 | 0.041 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.025 0.01 CID_1983 | ||
| 0.088 | 0.052 | 0.088 | ErbB-3 antagonist | |||
| 0.089 | 0.053 | 0.095 | Bcr-Abl kinase inhibitor | 0.095 0.045 CID_1983 | CID_1983 | |
| 0.101 | 0.065 | 0.101 | Gastric antisecretory | |||
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | 0.084 0.051 CID_1983 | ||
| 0.08 | 0.045 | 0.115 | MAP kinase kinase 7 inhibitor | 0.115 0.005 CID_1983 | CID_1983 | |
| 0.077 | 0.042 | 0.077 | Potassium channel (Tandem pore domain) blocker | |||
| 0.072 | 0.038 | 0.072 | Histone deacetylase inhibitor | 0.071 0.039 CID_1983 | ||
| 0.059 | 0.025 | 0.082 | Beta 2 adrenoreceptor antagonist | 0.082 0.011 CID_1983 | CID_1983 | |
| 0.093 | 0.06 | 0.093 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.048 | 0.015 | 0.048 | Potassium channel Kv1.1 blocker | 0.044 0.018 CID_1983 | ||
| 0.045 | 0.013 | 0.045 | Vanilloid 3 antagonist | |||
| 0.1 | 0.068 | 0.146 | Adenylate kinase inhibitor | 0.146 0.028 CID_1983 | CID_1983 | |
| 0.149 | 0.117 | 0.159 | Psychostimulant | 0.159 0.108 CID_1983 | CID_1983 | |
| 0.077 | 0.046 | 0.077 | Metalloproteinase-9 inhibitor | 0.073 0.051 CID_1983 | ||
| 0.1 | 0.069 | 0.134 | Beta glucuronidase inhibitor | 0.134 0.034 CID_1983 | CID_1983 | |
| 0.046 | 0.015 | 0.056 | Glutamate (mGluR8) agonist | 0.056 0.008 CID_1983 | CID_1983 | |
| 0.059 | 0.029 | 0.067 | DNA helicase inhibitor | 0.067 0.02 CID_1983 | CID_1983 | |
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | 0.062 0.044 CID_1983 | ||
| 0.077 | 0.048 | 0.084 | Histone deacetylase SIRT2 inhibitor | 0.084 0.042 CID_1983 | CID_1983 | |
| 0.052 | 0.023 | 0.052 | Fructose-1,6-bisphosphatase inhibitor | 0.049 0.026 CID_1983 | ||
| 0.058 | 0.03 | 0.081 | Dihydroorotate dehydrogenase inhibitor | 0.081 0.018 CID_1983 | CID_1983 | |
| 0.063 | 0.036 | 0.097 | Heat shock protein 90 beta antagonist | 0.097 0.012 CID_1983 | CID_1983 | |
| 0.131 | 0.105 | 0.131 | MAP kinase 3 inhibitor | 0.126 0.117 CID_1983 | ||
| 0.067 | 0.041 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 CID_1983 | CID_1983 | |
| 0.05 | 0.025 | 0.078 | Purinergic P2X4 antagonist | 0.078 0.007 CID_1983 | CID_1983 | |
| 0.029 | 0.005 | 0.041 | Neuraminidase (Influenza B) inhibitor | 0.041 0.003 CID_1983 | CID_1983 | |
| 0.047 | 0.023 | 0.078 | CDK5/p25 inhibitor | 0.078 0.009 CID_1983 | CID_1983 | |
| 0.049 | 0.025 | 0.071 | Carbonic anhydrase IV inhibitor | 0.071 0.014 CID_1983 | CID_1983 | |
| 0.128 | 0.104 | 0.148 | Phospholipase A2 inhibitor | 0.148 0.076 CID_1983 | CID_1983 | |
| 0.066 | 0.042 | 0.097 | Carbonic anhydrase inhibitor | 0.097 0.028 CID_1983 | CID_1983 | |
| 0.057 | 0.033 | 0.057 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.1 | 0.076 | 0.164 | DOPA decarboxylase inhibitor | 0.164 0.015 CID_1983 | CID_1983 | |
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.059 | 0.036 | 0.081 | Carbonic anhydrase I inhibitor | 0.081 0.025 CID_1983 | CID_1983 | |
| 0.038 | 0.016 | 0.038 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.053 | 0.03 | 0.074 | CD45 antagonist | 0.074 0.014 CID_1983 | CID_1983 | |
| 0.058 | 0.035 | 0.065 | Leukotriene C antagonist | 0.065 0.02 CID_1983 | CID_1983 | |
| 0.119 | 0.097 | 0.119 | Nav1.6 sodium channel blocker | |||
| 0.1 | 0.078 | 0.168 | GABA C receptor antagonist | 0.168 0.022 CID_1983 | CID_1983 | |
| 0.062 | 0.041 | 0.08 | Beta 2 adrenoreceptor agonist | 0.08 0.009 CID_1983 | CID_1983 | |
| 0.058 | 0.037 | 0.082 | Carbonic anhydrase II inhibitor | 0.082 0.024 CID_1983 | CID_1983 | |
| 0.037 | 0.015 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 CID_1983 | CID_1983 | |
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase X inhibitor | 0.024 0.006 CID_1983 | ||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 CID_1983 | ||
| 0.1 | 0.079 | 0.1 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.072 | 0.051 | 0.086 | Glycine receptor agonist | 0.086 0.032 CID_1983 | CID_1983 | |
| 0.057 | 0.038 | 0.057 | Pregnane X receptor antagonist | 0.056 0.04 CID_1983 | ||
| 0.023 | 0.003 | 0.023 | Melatonin 2 antagonist | |||
| 0.053 | 0.034 | 0.074 | Factor IXa inhibitor | 0.074 0.018 CID_1983 | CID_1983 | |
| 0.088 | 0.069 | 0.152 | Prolactin inhibitor | 0.152 0.021 CID_1983 | CID_1983 | |
| 0.072 | 0.054 | 0.103 | Vanilloid antagonist | 0.103 0.034 CID_1983 | CID_1983 | |
| 0.09 | 0.072 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 CID_1983 | CID_1983 | |
| 0.043 | 0.025 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.061 0.007 CID_1983 | CID_1983 | |
| 0.027 | 0.01 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 CID_1983 | ||
| 0.071 | 0.054 | 0.071 | Nav1.8 sodium channel blocker | |||
| 0.058 | 0.041 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 CID_1983 | CID_1983 | |
| 0.026 | 0.009 | 0.026 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.056 | 0.039 | 0.056 | 5 Hydroxytryptamine 7 agonist | |||
| 0.03 | 0.013 | 0.03 | Hedgehog signaling activator | 0.026 0.023 CID_1983 | ||
| 0.043 | 0.027 | 0.043 | Histone deacetylase 8 inhibitor | 0.043 0.027 CID_1983 | ||
| 0.045 | 0.029 | 0.069 | AICAR transformylase inhibitor | 0.069 0.01 CID_1983 | CID_1983 | |
| 0.044 | 0.028 | 0.051 | Glutamate (mGluR group III) agonist | 0.051 0.023 CID_1983 | CID_1983 | |
| 0.125 | 0.109 | 0.159 | Cyclin-dependent kinase 8 inhibitor | 0.159 0.071 CID_1983 | CID_1983 | |
| 0.081 | 0.065 | 0.092 | Myeloperoxidase inhibitor | 0.092 0.046 CID_1983 | CID_1983 | |
| 0.047 | 0.031 | 0.053 | Adenylate cyclase 1 inhibitor | 0.053 0.023 CID_1983 | CID_1983 | |
| 0.035 | 0.02 | 0.035 | Calcium release-activated channel blocker | |||
| 0.052 | 0.037 | 0.055 | Vanilloid 2 antagonist | 0.055 0.03 CID_1983 | CID_1983 | |
| 0.02 | 0.004 | 0.02 | Carbonic anhydrase XI inhibitor | 0.018 0.005 CID_1983 | ||
| 0.029 | 0.014 | 0.057 | Thyroid hormone agonist | 0.057 0.004 CID_1983 | CID_1983 | |
| 0.047 | 0.032 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.073 | 0.059 | 0.136 | Topoisomerase II alpha inhibitor | 0.136 0.026 CID_1983 | CID_1983 | |
| 0.07 | 0.056 | 0.254 | Porphobilinogen synthase inhibitor | 0.254 0.007 CID_1983 | CID_1983 | |
| 0.043 | 0.029 | 0.043 | Leukocyte elastase inhibitor | |||
| 0.049 | 0.035 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.088 | 0.075 | 0.246 | Creatine kinase inhibitor | 0.246 0.006 CID_1983 | CID_1983 | |
| 0.033 | 0.02 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.023 | 0.01 | 0.023 | Factor XIII inhibitor | 0.021 0.014 CID_1983 | ||
| 0.058 | 0.045 | 0.058 | Phosphodiesterase 1B inhibitor | |||
| 0.039 | 0.027 | 0.045 | Histone deacetylase 9 inhibitor | 0.045 0.02 CID_1983 | CID_1983 | |
| 0.067 | 0.055 | 0.099 | Telomerase inhibitor | 0.099 0.034 CID_1983 | CID_1983 | |
| 0.052 | 0.04 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.021 CID_1983 | CID_1983 | |
| 0.057 | 0.045 | 0.097 | Androgen agonist | 0.097 0.016 CID_1983 | CID_1983 | |
| 0.039 | 0.027 | 0.039 | Histone deacetylase class I inhibitor | 0.036 0.03 CID_1983 | ||
| 0.037 | 0.026 | 0.04 | Histone deacetylase 7 inhibitor | 0.04 0.023 CID_1983 | CID_1983 | |
| 0.072 | 0.062 | 0.075 | Metalloproteinase-2 inhibitor | 0.075 0.058 CID_1983 | CID_1983 | |
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 CID_1983 | ||
| 0.029 | 0.019 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.009 CID_1983 | CID_1983 | |
| 0.084 | 0.074 | 0.099 | Thioredoxin inhibitor | 0.099 0.049 CID_1983 | CID_1983 | |
| 0.103 | 0.093 | 0.103 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.016 | 0.006 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 CID_1983 | ||
| 0.029 | 0.019 | 0.043 | Estrogen-related receptor gamma antagonist | 0.043 0.004 CID_1983 | CID_1983 | |
| 0.046 | 0.037 | 0.046 | Cholesterol esterase inhibitor | |||
| 0.047 | 0.038 | 0.047 | Potassium channel (Inward rectifier) blocker | |||
| 0.059 | 0.05 | 0.059 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.144 | 0.135 | 0.202 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.202 0.091 CID_1983 | CID_1983 | |
| 0.032 | 0.023 | 0.042 | Glutamate (mGluR3) agonist | 0.042 0.008 CID_1983 | CID_1983 | |
| 0.019 | 0.01 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 CID_1983 | CID_1983 | |
| 0.056 | 0.048 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.013 CID_1983 | CID_1983 | |
| 0.055 | 0.048 | 0.055 | Collagenase 3 inhibitor | |||
| 0.033 | 0.026 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.019 CID_1983 | CID_1983 | |
| 0.101 | 0.094 | 0.151 | Interleukin 8 antagonist | 0.151 0.033 CID_1983 | CID_1983 | |
| 0.044 | 0.038 | 0.044 | CC chemokine 4 receptor antagonist | |||
| 0.053 | 0.046 | 0.055 | Cyclin E inhibitor | 0.055 0.044 CID_1983 | CID_1983 | |
| 0.047 | 0.041 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.118 | 0.111 | 0.135 | Aurora-C kinase inhibitor | 0.135 0.074 CID_1983 | CID_1983 | |
| 0.049 | 0.043 | 0.072 | Carbonic anhydrase IX inhibitor | 0.072 0.031 CID_1983 | CID_1983 | |
| 0.028 | 0.022 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.039 | 0.033 | 0.039 | Plasmepsin II inhibitor | |||
| 0.018 | 0.012 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | 0.02 0.009 CID_1983 | CID_1983 | |
| 0.033 | 0.027 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 CID_1983 | CID_1983 | |
| 0.084 | 0.078 | 0.145 | Protein kinase (CK2) inhibitor | 0.145 0.035 CID_1983 | CID_1983 | |
| 0.056 | 0.051 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 CID_1983 | CID_1983 | |
| 0.025 | 0.02 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.073 | 0.068 | 0.135 | Adrenaline agonist | 0.135 0.019 CID_1983 | CID_1983 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.018 | 0.013 | 0.036 | Estrogen-related receptor gamma agonist | 0.036 0.003 CID_1983 | CID_1983 | |
| 0.063 | 0.058 | 0.073 | Glutamate (mGluR6) antagonist | 0.073 0.035 CID_1983 | CID_1983 | |
| 0.053 | 0.048 | 0.053 | Fibroblast growth factor 4 antagonist | |||
| 0.057 | 0.053 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.066 | 0.062 | 0.125 | Glutamate dehydrogenase inhibitor | 0.125 0.021 CID_1983 | CID_1983 | |
| 0.079 | 0.076 | 0.079 | MAO B inhibitor | 0.079 0.076 CID_1983 | ||
| 0.013 | 0.009 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.03 | 0.026 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 CID_1983 | CID_1983 | |
| 0.053 | 0.049 | 0.107 | Biliverdin reductase inhibitor | 0.107 0.017 CID_1983 | CID_1983 | |
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.069 | 0.066 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.048 | 0.045 | 0.087 | Acyl-CoA dehydrogenase inhibitor | 0.087 0.02 CID_1983 | CID_1983 | |
| 0.059 | 0.056 | 0.059 | Aryl hydrocarbon receptor antagonist | |||
| 0.026 | 0.023 | 0.026 | Glucosylceramidase stimulant | |||
| 0.037 | 0.035 | 0.042 | Leukotriene C4 antagonist | 0.042 0.019 CID_1983 | CID_1983 | |
| 0.035 | 0.033 | 0.045 | Alpha 1d adrenoreceptor agonist | 0.045 0.021 CID_1983 | CID_1983 | |
| 0.044 | 0.043 | 0.074 | Carbonic anhydrase XII inhibitor | 0.074 0.028 CID_1983 | CID_1983 | |
| 0.077 | 0.076 | 0.077 | mTOR complex 2 inhibitor | |||
| 0.05 | 0.049 | 0.051 | Epithelial sodium channel blocker | 0.051 0.046 CID_1983 | CID_1983 | |
| 0.058 | 0.057 | 0.058 | Matrix metalloproteinase inhibitor | |||
| 0.04 | 0.039 | 0.063 | Glycine transporter 2 inhibitor | 0.063 0.024 CID_1983 | CID_1983 | |
| 0.025 | 0.024 | 0.025 | Toll-Like receptor 4 agonist | |||
| 0.043 | 0.043 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 CID_1983 | CID_1983 | |
| 0.092 | 0.092 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.053 CID_1983 | CID_1983 | |
| 0.021 | 0.021 | 0.048 | NMDA receptor glycine site antagonist | 0.048 0.006 CID_1983 | CID_1983 | |
| 0.017 | 0.017 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.013 CID_1983 | CID_1983 | |
| 0.038 | 0.038 | 0.043 | Kainate receptor agonist | 0.043 0.024 CID_1983 | CID_1983 | |
| 0.043 | 0.044 | 0.056 | Beta adrenoreceptor agonist | 0.056 0.01 CID_1983 | CID_1983 | |
| 0.119 | 0.12 | 0.13 | Thiol protease inhibitor | 0.13 0.097 CID_1983 | CID_1983 | |
| 0.054 | 0.055 | 0.059 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.041 CID_1983 | CID_1983 | |
| 0.039 | 0.042 | 0.054 | Mannosidase inhibitor | 0.054 0.021 CID_1983 | CID_1983 | |
| 0.067 | 0.069 | 0.068 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.066 CID_1983 | CID_1983 | |
| 0.072 | 0.075 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 CID_1983 | CID_1983 | |
| 0.051 | 0.053 | 0.061 | Carbonic anhydrase stimulant | 0.061 0.04 CID_1983 | CID_1983 | |
| 0.141 | 0.145 | 0.193 | Dyrk kinase inhibitor | 0.193 0.102 CID_1983 | CID_1983 | |
| 0.036 | 0.04 | 0.053 | Sphingosine kinase 1 inhibitor | 0.053 0.014 CID_1983 | CID_1983 | |
| 0.013 | 0.017 | 0.018 | Adenosine A2 receptor agonist | 0.018 0.009 CID_1983 | CID_1983 | |
| 0.045 | 0.05 | 0.051 | Factor III inhibitor | 0.051 0.031 CID_1983 | CID_1983 | |
| 0.017 | 0.022 | 0.02 | Caspase 8 inhibitor | 0.02 0.013 CID_1983 | CID_1983 | |
| 0.069 | 0.074 | 0.086 | Sphingosine 1-phosphate receptor antagonist | 0.086 0.035 CID_1983 | CID_1983 | |
| 0.075 | 0.081 | 0.127 | Potassium channel (Ca-activated) activator | 0.127 0.037 CID_1983 | CID_1983 | |
| 0.014 | 0.02 | 0.042 | Nicotinic acid receptor 1 antagonist | 0.042 0.003 CID_1983 | CID_1983 | |
| 0.075 | 0.083 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.072 CID_1983 | CID_1983 | |
| 0.005 | 0.014 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 CID_1983 | CID_1983 | |
| 0.049 | 0.058 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 CID_1983 | CID_1983 | |
| 0.018 | 0.027 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.01 CID_1983 | CID_1983 | |
| 0.082 | 0.094 | 0.127 | Cyclin-dependent kinase 5 inhibitor | 0.127 0.054 CID_1983 | CID_1983 | |
| 0.044 | 0.056 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.094 0.012 CID_1983 | CID_1983 | |
| 0.041 | 0.054 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.039 CID_1983 | CID_1983 | |
| 0.035 | 0.048 | 0.043 | Nerve growth factor antagonist | 0.043 0.03 CID_1983 | CID_1983 | |
| 0.075 | 0.088 | 0.157 | Aminopeptidase B inhibitor | 0.157 0.035 CID_1983 | CID_1983 | |
| 0.134 | 0.147 | 0.15 | EphB2 antagonist | 0.15 0.13 CID_1983 | CID_1983 | |
| 0.101 | 0.115 | 0.207 | Lipid peroxidase inhibitor | 0.207 0.039 CID_1983 | CID_1983 | |
| 0.078 | 0.092 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.046 CID_1983 | CID_1983 | |
| 0.028 | 0.042 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.028 CID_1983 | CID_1983 | |
| 0.024 | 0.04 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 CID_1983 | CID_1983 | |
| 0.079 | 0.095 | 0.123 | Xanthine oxidase inhibitor | 0.123 0.046 CID_1983 | CID_1983 | |
| 0.141 | 0.157 | 0.286 | Free radical scavenger | 0.286 0.055 CID_1983 | CID_1983 | |
| 0.02 | 0.036 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.031 0.012 CID_1983 | CID_1983 | |
| 0.021 | 0.038 | 0.027 | Caspase 2 inhibitor | 0.027 0.026 CID_1983 | CID_1983 | |
| 0.048 | 0.066 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.019 CID_1983 | CID_1983 | |
| 0.102 | 0.119 | 0.118 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.118 0.103 CID_1983 | CID_1983 | |
| 0.011 | 0.028 | 0.015 | Thromboxane A2 agonist | 0.015 0.012 CID_1983 | CID_1983 | |
| 0.074 | 0.092 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 CID_1983 | CID_1983 | |
| 0.025 | 0.044 | 0.076 | Nicotinic acid receptor agonist | 0.076 0.007 CID_1983 | CID_1983 | |
| 0.151 | 0.171 | 0.251 | Streptokinase A inhibitor | 0.251 0.102 CID_1983 | CID_1983 | |
| 0.022 | 0.043 | 0.03 | Cyclophilin A inhibitor | 0.03 0.022 CID_1983 | CID_1983 | |
| 0.112 | 0.134 | 0.18 | Growth hormone agonist | 0.18 0.068 CID_1983 | CID_1983 | |
| 0.056 | 0.078 | 0.138 | Glutamate decarboxylase inhibitor | 0.138 0.015 CID_1983 | CID_1983 | |
| 0.044 | 0.066 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.084 0.027 CID_1983 | CID_1983 | |
| 0.092 | 0.114 | 0.149 | Aldehyde dehydrogenase inhibitor | 0.149 0.048 CID_1983 | CID_1983 | |
| 0.061 | 0.085 | 0.085 | Macrophage migration inhibitory factor inhibitor | 0.085 0.045 CID_1983 | CID_1983 | |
| 0.026 | 0.051 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.031 CID_1983 | CID_1983 | |
| 0.014 | 0.04 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_1983 | CID_1983 | |
| 0.011 | 0.038 | 0.036 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.036 0.01 CID_1983 | CID_1983 | |
| 0.004 | 0.03 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 CID_1983 | CID_1983 | |
| 0.201 | 0.228 | 0.318 | Antibacterial | 0.318 0.122 CID_1983 | CID_1983 | |
| 0.021 | 0.049 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 CID_1983 | CID_1983 | |
| 0.049 | 0.077 | 0.187 | Phenylalanine 4-hydroxylase inhibitor | 0.187 0.008 CID_1983 | CID_1983 | |
| 0.045 | 0.074 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.034 CID_1983 | CID_1983 | |
| 0.061 | 0.091 | 0.072 | Interferon agonist | 0.072 0.066 CID_1983 | CID_1983 | |
| 0.079 | 0.109 | 0.111 | AMP-activated protein kinase stimulant | 0.111 0.058 CID_1983 | CID_1983 | |
| 0.041 | 0.071 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 CID_1983 | CID_1983 | |
| 0.142 | 0.173 | 0.169 | Spasmolytic | 0.169 0.146 CID_1983 | CID_1983 | |
| 0.07 | 0.101 | 0.145 | Alcohol dehydrogenase inhibitor | 0.145 0.022 CID_1983 | CID_1983 | |
| 0.053 | 0.084 | 0.101 | Aminopeptidase I inhibitor | 0.101 0.027 CID_1983 | CID_1983 | |
| 0.078 | 0.11 | 0.15 | Adenylate cyclase inhibitor | 0.15 0.045 CID_1983 | CID_1983 | |
| 0.051 | 0.085 | 0.061 | Interferon inducer | 0.061 0.052 CID_1983 | CID_1983 | |
| 0.106 | 0.14 | 0.159 | Farnesoid X receptor antagonist | 0.159 0.043 CID_1983 | CID_1983 | |
| 0.013 | 0.049 | 0.021 | Glutamate (mGluR1a) agonist | 0.021 0.017 CID_1983 | CID_1983 | |
| 0.048 | 0.085 | 0.067 | Prostaglandin-E synthase inhibitor | 0.067 0.053 CID_1983 | CID_1983 | |
| 0.036 | 0.074 | 0.072 | Argininosuccinate synthase inhibitor | 0.072 0.029 CID_1983 | CID_1983 | |
| 0.026 | 0.065 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.031 CID_1983 | CID_1983 | |
| 0.034 | 0.074 | 0.081 | Maillard reaction inhibitor | 0.081 0.024 CID_1983 | CID_1983 | |
| 0.025 | 0.065 | 0.039 | Protein kinase (CK2) beta inhibitor | 0.039 0.013 CID_1983 | CID_1983 | |
| 0.042 | 0.083 | 0.102 | Phosphofructokinase-1 inhibitor | 0.102 0.031 CID_1983 | CID_1983 | |
| 0.036 | 0.077 | 0.051 | Aconitate hydratase inhibitor | 0.051 0.036 CID_1983 | CID_1983 | |
| 0.036 | 0.078 | 0.049 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.049 0.047 CID_1983 | CID_1983 | |
| 0.022 | 0.064 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | 0.053 0.023 CID_1983 | CID_1983 | |
| 0.081 | 0.124 | 0.135 | MAP kinase kinase inhibitor | 0.135 0.061 CID_1983 | CID_1983 | |
| 0.078 | 0.122 | 0.098 | Cholesterol synthesis inhibitor | 0.098 0.09 CID_1983 | CID_1983 | |
| 0.024 | 0.068 | 0.072 | Dopamine D5 agonist | 0.072 0.008 CID_1983 | CID_1983 | |
| 0.031 | 0.075 | 0.062 | Xanthine dehydrogenase inhibitor | 0.062 0.037 CID_1983 | CID_1983 | |
| 0.078 | 0.124 | 0.188 | M18 aspartyl aminopeptidase inhibitor | 0.188 0.037 CID_1983 | CID_1983 | |
| 0.025 | 0.071 | 0.047 | Adenosine deaminase inhibitor | 0.047 0.033 CID_1983 | CID_1983 | |
| 0.026 | 0.072 | 0.084 | NMDA receptor subunit 3B antagonist | 0.084 0.013 CID_1983 | CID_1983 | |
| 0.107 | 0.153 | 0.22 | Angiogenesis stimulant | 0.22 0.084 CID_1983 | CID_1983 | |
| 0.045 | 0.093 | 0.069 | I kappa B kinase 2 inhibitor | 0.069 0.033 CID_1983 | CID_1983 | |
| 0.114 | 0.162 | 0.142 | Interleukin 6 antagonist | 0.142 0.101 CID_1983 | CID_1983 | |
| 0.027 | 0.076 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.037 CID_1983 | CID_1983 | |
| 0.058 | 0.108 | 0.084 | I kappa B kinase inhibitor | 0.084 0.055 CID_1983 | CID_1983 | |
| 0.039 | 0.092 | 0.054 | Glucosylceramidase inhibitor | 0.054 0.04 CID_1983 | CID_1983 | |
| 0.023 | 0.078 | 0.049 | Phosphorylase inhibitor | 0.049 0.031 CID_1983 | CID_1983 | |
| 0.055 | 0.111 | 0.092 | Histamine N-methyltransferase inhibitor | 0.092 0.053 CID_1983 | CID_1983 | |
| 0.033 | 0.092 | 0.066 | Selectin antagonist | 0.066 0.045 CID_1983 | CID_1983 | |
| 0.02 | 0.08 | 0.051 | Oxytocin agonist | 0.051 0.023 CID_1983 | CID_1983 | |
| 0.023 | 0.083 | 0.07 | Ribonucleoside-diphosphate reductase inhibitor | 0.07 0.029 CID_1983 | CID_1983 | |
| 0.033 | 0.094 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.034 CID_1983 | CID_1983 | |
| 0.011 | 0.072 | 0.032 | CXC chemokine 2 receptor antagonist | 0.032 0.013 CID_1983 | CID_1983 | |
| 0.13 | 0.192 | 0.273 | Antioxidant | 0.273 0.073 CID_1983 | CID_1983 | |
| 0.036 | 0.098 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.043 CID_1983 | CID_1983 | |
| 0.022 | 0.085 | 0.071 | Ribonucleotide reductase inhibitor | 0.071 0.031 CID_1983 | CID_1983 | |
| 0.033 | 0.096 | 0.068 | CXC chemokine 1 receptor antagonist | 0.068 0.014 CID_1983 | CID_1983 | |
| 0.05 | 0.114 | 0.079 | Ornithine decarboxylase inhibitor | 0.079 0.068 CID_1983 | CID_1983 | |
| 0.105 | 0.17 | 0.149 | Dual specificity phosphatase inhibitor | 0.149 0.095 CID_1983 | CID_1983 | |
| 0.023 | 0.09 | 0.048 | Ornithine carbamoyltransferase inhibitor | 0.048 0.042 CID_1983 | CID_1983 | |
| 0.02 | 0.088 | 0.081 | NMDA 2A receptor antagonist | 0.081 0.019 CID_1983 | CID_1983 | |
| 0.016 | 0.087 | 0.036 | Nicotinic acid receptor 2 agonist | 0.036 0.024 CID_1983 | CID_1983 | |
| 0.096 | 0.169 | 0.14 | Dual specificity phosphatase 3 inhibitor | 0.14 0.105 CID_1983 | CID_1983 | |
| 0.04 | 0.114 | 0.068 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 CID_1983 | CID_1983 | |
| 0.112 | 0.19 | 0.144 | Death-associated protein kinase 3 inhibitor | 0.144 0.133 CID_1983 | CID_1983 | |
| 0.055 | 0.133 | 0.072 | Vanilloid 4 agonist | 0.072 0.059 CID_1983 | CID_1983 | |
| 0.016 | 0.095 | 0.057 | NMDA receptor subunit 3A antagonist | 0.057 0.018 CID_1983 | CID_1983 | |
| 0.088 | 0.168 | 0.13 | Diuretic | 0.13 0.094 CID_1983 | CID_1983 | |
| 0.031 | 0.112 | 0.124 | NMDA 2 receptor antagonist | 0.124 0.023 CID_1983 | CID_1983 | |
| 0.061 | 0.142 | 0.131 | Topoisomerase II inhibitor | 0.131 0.059 CID_1983 | CID_1983 | |
| 0.034 | 0.118 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | 0.084 0.032 CID_1983 | CID_1983 | |
| 0.029 | 0.118 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.028 CID_1983 | CID_1983 | |
| 0.007 | 0.097 | 0.034 | Arginase inhibitor | 0.034 0.028 CID_1983 | CID_1983 | |
| 0.033 | 0.123 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 CID_1983 | CID_1983 | |
| 0.059 | 0.153 | 0.079 | Interleukin 5 antagonist | 0.079 0.075 CID_1983 | CID_1983 | |
| 0.038 | 0.132 | 0.064 | Sirtuin 1 inhibitor | 0.064 0.053 CID_1983 | CID_1983 | |
| 0.045 | 0.141 | 0.133 | NMDA receptor antagonist | 0.133 0.03 CID_1983 | CID_1983 | |
| 0.052 | 0.15 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.049 CID_1983 | CID_1983 | |
| 0.09 | 0.192 | 0.203 | NOS3 expression enhancer | 0.203 0.039 CID_1983 | CID_1983 | |
| 0.079 | 0.19 | 0.147 | Mcl-1 antagonist | 0.147 0.092 CID_1983 | CID_1983 | |
| 0.009 | 0.12 | 0.052 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.052 0.015 CID_1983 | CID_1983 | |
| 0.021 | 0.15 | 0.059 | HIV-1 integrase (Strand Transfer) inhibitor | 0.059 0.042 CID_1983 | CID_1983 | |
| 0.03 | 0.159 | 0.064 | Protein kinase C beta inhibitor | 0.064 0.059 CID_1983 | CID_1983 | |
| 0.059 | 0.189 | 0.088 | Hematopoietic | 0.088 0.054 CID_1983 | CID_1983 | |
| 0.05 | 0.186 | 0.139 | Chelator | 0.139 0.04 CID_1983 | CID_1983 | |
| 0.07 | 0.213 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.098 CID_1983 | CID_1983 | |
| 0.046 | 0.238 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 CID_1983 | CID_1983 | |
| 0.05 | 0.244 | 0.103 | Nav1.4 sodium channel blocker | 0.103 0.072 CID_1983 | CID_1983 | |
| 0.098 | 0.301 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.117 CID_1983 | CID_1983 | |
| 0.042 | 0.252 | 0.149 | Estrogen receptor beta antagonist | 0.149 0.016 CID_1983 | CID_1983 | |
| 0.018 | 0.233 | 0.054 | NMDA 2B receptor antagonist | 0.054 0.037 CID_1983 | CID_1983 | |
| 0.007 | 0.242 | 0.059 | Estrogen agonist | 0.059 0.031 CID_1983 | CID_1983 | |
| 0.048 | 0.3 | 0.157 | Estrogen antagonist | 0.157 0.021 CID_1983 | CID_1983 | |
| 0.012 | 0.293 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 CID_1983 | CID_1983 | |
| 0.003 | 0.286 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 CID_1983 | CID_1983 | |
| 0.003 | 0.312 | 0.034 | Estrogen receptor alpha agonist | 0.034 0.024 CID_1983 | CID_1983 | |
| 0.024 | 0.356 | 0.077 | Opioid antagonist | 0.077 0.074 CID_1983 | CID_1983 | |
| 0.07 | 0.434 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.118 CID_1983 | CID_1983 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |